This tool estimates the 2-week risk of treatment-requiring ROP from gestational age, postmenstrual age, and P-score (a measure of vascular severity).
It should be used to assist in determining whether a 1-week vs 2-week follow-up exam is necessary.
Its aim is to support, not replace, clinical judgment and is for investigational use only.
It has only been validated for use on US populations.
